Thermo Fisher Scientific expands ImmunoCAP test availability across US

IMT News Desk
IMT News Desk
· 2 min read

Testing supporting allergy diagnosis now accessible to more people in more communities

Thermo Fisher Scientific announced it is making ImmunoCAP Specific IgE tests available to more patients across the US. The ImmunoCAP tests are now available to patients at all Kroger Health The Little Clinic LLC (The Little Clinic) locations, through a blood draw taken on-site.

The ImmunoCAP specific IgE regional respiratory profiles now offered at The Little Clinic require one blood draw that is analysed at an offsite clinical laboratory. These tests are not new to the industry and are backed by 50+ years of research and development. This expansion into The Little Clinic sites will help enable more patients to take actionable preventative health steps to mitigate their allergies.

The Asthma and Allergy Foundation of America estimates that more than 100 million Americans experience various types of allergies each year, with allergies being the sixth leading cause of chronic illness in the US. Identifying potential allergic triggers is an important component of managing patients presenting with upper and lower respiratory symptoms.

“Discovering the actual cause of allergy-like symptoms is vital to empowering patients to address their condition from a preventative medicine standpoint, allowing a more personalised management plan,” said Gary Falcetano, PA-C, AE-C, scientific affairs manager, Thermo Fisher Scientific. “Adding trusted and accurate ImmunoCAP testing to all The Little Clinic locations will enable clinicians to help many more patients get the answers they need to proactively manage their health.”

The Little Clinic’s onsite licensed healthcare professionals provide credible and convenient care to patients in a neighbourhood grocery store. These clinicians can deliver personalised care through a variety of convenient, low-cost treatment, screening, and diagnostic services. Offering the ImmunoCAP blood test in local communities is one more service that makes healthcare accessible and convenient to patients.

Documented in more than 4,000 peer-reviewed publications and referenced in health guidelines around the globe, ImmunoCAP blood tests can help identify allergic sensitization to common environmental allergens – seasonal and perennial, indoor and outdoor.

ImmunoCAP specific IgE tests are the gold standard in in-vitro allergy diagnostics with hundreds of whole allergen, allergen mixes, and allergen component tests, which can be performed irrespective of a patient’s age, skin condition, medication, disease activity, and pregnancy.

Read Next

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences
Global News
January 20, 2026

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences

To advance BOT+BAL and strengthen US manufacturing readiness Agenus, a leader in immuno-oncology innovation, announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to accelerate global development and potential commercialisation of Agenus’ botensilimab and balstilimab (BOT+BAL) immunotherapy combination programme. The collaboration provides Agenus with strategic capital and […]
Article by: IMT News Desk
Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia
Global News
January 16, 2026

Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia

Approval marks Venus Remedies’ first anti-infective marketing authorisation in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies has secured the marketing authorisation from the Indonesian regulatory authority for its combination antibiotic, Ceftazidime + Avibactam. This approval represents Venus Remedies’ first marketing authorization in the anti-infective segment in Indonesia […]
Article by: IMT News Desk
Wegovy pill approved in the US for weight management
Global News
December 26, 2025

Wegovy pill approved in the US for weight management

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026 Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse […]
Article by: IMT News Desk
Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK
Global News
December 24, 2025

Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK

Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, Samsung Biologics will acquire the Rockville assets for $280 million Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100 […]
Article by: IMT News Desk